RNA, 7SL, cytoplasmic 733, pseudogene (RN7SL733P)

RN7SL733P (RNA, 7SL, cytoplasmic 733, pseudogene) is classified as a **pseudogene** in the human genome[1]. It is a truncated, non-functional genomic sequence derived from the functional 7SL RNA gene, which plays a role in the signal recognition particle (SRP) pathway critical for protein targeting to the endoplasmic reticulum in eukaryotic cells[3][5]. However, unlike the parental 7SL RNA, pseudogenes such as RN7SL733P do **not code for functional products** and typically do not participate in cellular signaling, enzymatic activity, or molecular transport[1][3]. Pseudogenes may have residual transcription in some cases and, as a class, can sometimes produce non-coding RNAs with putative regulatory roles, such as acting as miRNA "sponges" (competing endogenous RNAs) or sources of small interfering RNAs, but this is not established for most individual 7SL pseudogenes including RN7SL733P[4]. They are not considered **therapeutic targets**, do not bind drugs, and do not serve as clinical biomarkers. There is no evidence that RN7SL733P is functionally implicated in any disease, either as a direct contributor or as a diagnostic or prognostic marker[1][3]. Because "RN7SL733P" is a pseudogene, it does **not represent a receptor, enzyme, transporter, or classic drug target**, and returning it as a druggable target would be incorrect[1][3]. **Note** The canonical, functional version of 7SL RNA participates in key processes such as protein targeting and has been implicated in cancer biology and cell proliferation[5], but these properties do not extend to its processed pseudogenes such as RN7SL733P.

Other names

RN7SL733P